CVS Health Corporation (CVS)
| Market Cap | 95.10B |
| Revenue (ttm) | 384.33B |
| Net Income (ttm) | 4.53B |
| Shares Out | 1.27B |
| EPS (ttm) | 3.59 |
| PE Ratio | 20.88 |
| Forward PE | 11.37 |
| Dividend | $2.66 (3.55%) |
| Ex-Dividend Date | Jul 22, 2025 |
| Volume | 6,400,167 |
| Open | 74.42 |
| Previous Close | 74.67 |
| Day's Range | 74.42 - 75.55 |
| 52-Week Range | 43.56 - 75.55 |
| Beta | 0.62 |
| Analysts | Strong Buy |
| Price Target | 78.29 (+4.42%) |
| Earnings Date | Nov 5, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for CVS stock is "Strong Buy." The 12-month stock price target is $78.29, which is an increase of 4.42% from the latest price.
News
CVS Health Foundation awards $1 Million in Hometown Fund grants to boost local impact across Rhode Island
Grants will support local nonprofits improving health outcomes across the state WOONSOCKET, R.I. , Sept. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) Foundation announced today that it is awarding...
CVS Health Foundation awards $1 Million in Hometown Fund grants to boost local impact in Hartford
Grants will support local nonprofits improving health outcomes across the Greater Hartford area HARTFORD, Conn. , Sept. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) Foundation announced today that...
Stock Of The Day: Is CVS Headed Higher?
CVS Health Corporation CVS is trading higher on Tuesday. This follows yesterday's sell-off of almost 5%.
S&P 500 Gains and Losses Today: Uber Stock Drives Higher; CVS Slides
Major U.S. equities indexes ticked higher as markets kicked off a new trading week.
Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®
CVS Health ® survey finds more than 60 percent of consumers say they are likely to get a flu shot this season Enhanced flu testing and treatment offerings are also available in select CVS Pharmacy lo...
Top 10 High-Yield Dividend Stocks For September 2025
My watchlist outperformed SPY and VYM since July 1st, offering higher yield and competitive total returns, despite trailing benchmarks year-to-date. The strategy focuses on high-quality, attractively ...
CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
Jim Cramer talks what is driving CVS higher this year
'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.
Jim Cramer says CVS stock is a buy at these levels. Here's why
CNBC's Jim Cramer on Monday told investors why he's optimistic about CVS, even as the healthcare sector as a whole has lagged this year. "[It's] fixing its most problematic business, managed care, and...
The Big 3: LLY, BA, CVS
Dan Deming considers Friday's trading action after Jerome Powell's Jackson Hole speech "remarkable." On stocks he's watching ahead, he expects Eli Lilly (LLY) to rebound off a significant sell-off, Bo...
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
CVS Health Inc. CVS said it will not add Gilead Sciences Inc.'s GILD new HIV prevention drug Yeztugo to its commercial plans.
Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medic...
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules
CVS Health is not entitled to coverage from insurers, including AIG and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday.
CVS Health: Outlier In Healthcare Implosion - Further Margin Recovery Ahead
CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive improved YoY margins despite the rising medical costs. This is on top of the somew...
CVS Health: Health Insurers Get Buffett's Stamp Of Approval (Rating Upgrade)
Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the sector's business model remains intact despite recent headwinds. CVS has emerged...
Gill: We're at a real inflection point for healthcare
Lisa Gill, JP Morgan healthcare analyst, on “Worldwide Exchange,” says healthcare is at an inflection point, with UnitedHealth poised for long-term gains as big investors bet on a turnaround.
My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys
July saw strong market gains, especially in tech, but finding bargains is tough as indices approach all-time highs. I focused July investments on high-yield BDCs like OBDC, MFIC, and BXSL, maintaining...
CVS Health Corporation (CVS) Q2 2025 Earnings Call Transcript
CVS Health Corporation (NYSE:CVS) Q2 2025 Earnings Call July 31, 2025 8:00 AM ET Company Participants a - Corporate Participant v - Corporate Participant Brian O. Newman - Executive VP & CFO J.
The worst is behind CVS expect tailwinds ahead, says Raymond James' John Ransom
John Ransom, Raymond James director of health care research, joins 'Money Movers' to discuss the health care sector as the group has lagged in 2025.
5 Dividend Stocks With Solid Returns And More Growth Ahead
Sector by sector, U.S. dividend stocks have outperformed so far this year, with historically dividend-friendly industries surpassing those with a more growth-oriented focus.
CVS Targets Strong Weight-Loss Drug Use as Revenues Tick Up
CVS is focusing heavily on technology-led care after posting solid Q2 earnings. “We are building momentum as we navigate what continues to be a dynamic and evolving environment,” Chief Executive David...
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
CVS Health Corp CVS stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance.
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
Cramer's Mad Dash: CVS Health
Jim Cramer breaks down why he's keeping an eye on CVS Health.